Sculptor Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-48,700
Closed -$6.1M 738
2014
Q4
$6.1M Hold
48,700
0.02% 431
2014
Q3
$5.93M Hold
48,700
0.02% 491
2014
Q2
$5.75M Sell
48,700
-131,400
-73% -$15.5M 0.02% 493
2014
Q1
$21.7M Buy
180,100
+700
+0.4% +$83.2K 0.07% 254
2013
Q4
$20M Sell
179,400
-197,900
-52% -$19.7M 0.05% 341
2013
Q3
$34.8M Buy
377,300
+63,000
+20% +$5.7M 0.1% 262
2013
Q2
$26.6M Buy
+314,300
New +$26.2M 0.08% 281

Other funds holding TMO

Sculptor Capital's TMO Position: Q2 2026 in Review

Sculptor Capital opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 41,000 shares worth $20.6M. The stake represents 0.17% of the portfolio and ranks #118 among its holdings. This is a return to the name: Sculptor Capital previously reported a position in TMO as recently as Q1 2023.

Sculptor Capital first reported a position in TMO in Q2 2013 and has held it in 16 quarters since. The position peaked at $610M in Q4 2013. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Sculptor Capital held 41,000 shares of Thermo Fisher Scientific worth $20.6M as of Q2 2026.
  • Thermo Fisher Scientific was a new Sculptor Capital position in Q2 2026.
  • Thermo Fisher Scientific made up 0.17% of Sculptor Capital's portfolio in Q2 2026, its #118 holding.
  • Sculptor Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 16 quarters since.
  • Sculptor Capital's Thermo Fisher Scientific position peaked at $610M in Q4 2013.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sculptor Capital's 13F filing for Q2 2026, filed 14 Aug 2026.